Adapting medicine dosing to body size University of Queensland researchers are leading the charge in adapting medication dosing to a culture that is changing shape. As the known degree of obesity under western culture continues to go up dramatically, UQ College of Pharmacy’s Dr Bruce Green says researchers encounter the ongoing challenge of determining precisely how dosages should be altered for different body sizes and compositions. Modern Healthcare: Companies Want Medicare Payment Changes Tied To Quality HEALTHCARE providers are pressing for Medicare payment adjustments based on quality during the recently started post-election lame duck program of Congress. Blair Childs, Premier's senior vice president for authorities affairs, said in an interview that the alliance greater than 2,700 hospitals is urging a necessity that the CMS calculate the level to which hospitals possess reduced their Medicare costs recently when applying the deficit-related across-the-board lower .Browse the entire tale. This article is usually republished with kind permission from our friends at The Kaiser Family members Foundation. You will see the entire Kaiser Daily Health Plan Statement, search the archives, or join email delivery of in-depth coverage of wellness policy developments, debates and discussions. The Daily Health Plan Report is released for Kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. Copyright 2009 Advisory Panel Kaiser and Company Family Foundation. All rights reserved.
Antonio Palumbo, M.D., Federica Cavallo, M.D., Francesca Gay, M.D., Francesco Di Raimondo, M.D., Dina Ben Yehuda, M.D., Maria Teresa Petrucci, M.D., Sara Pezzatti, M.D., Tommaso Caravita, M.D., Chiara Cerrato, M.D., Elena Ribakovsky, M.D., Mariella Genuardi, M.D., Anna Cafro, M.D., Magda Marcatti, M.D., Lucio Catalano, M.D., Massimo Offidani, M.D., Angelo Michele Carella, M.D., Elena Zamagni, M.D., Francesca Patriarca, M.D., Pellegrino Musto, M.D., Andrea Evangelista, M.S., Giovannino Ciccone, M.D.D., Claudia Crippa, M.D., Paolo Corradini, M.D., Arnon Nagler, M.D., Mario Boccadoro, M.D., and Michele Cavo, M.D.: Autologous Transplantation and Maintenance Therapy in Multiple Myeloma High-dose chemotherapy plus autologous stem-cell transplantation, in comparison with conventional chemotherapy, prolongs progression-free survival and general survival among sufferers with diagnosed multiple myeloma newly.1-4 in fact it is currently the standard of look after patients who are young than 65 years of age.